Use of ribose in first response to acute myocardial infarction

Details Use of ribose in first response to acute myocardial infarction Use of ribose in first response to acute myocardial infarction

A - Human Necessities

61

K

A61K 31/7004 (2006.01) A61K 31/616 (2006.01) A61K 33/00 (2006.01) A61K 45/06 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2757442

D-ribose is administered to patients suffering an acute myocardial infarction during first response care, in order to prevent cardiac compromise. In those patients able to ingest fluids, two to five grams of D-ribose is administered orally. In a patients unable to ingest fluids, or in a patient with and intravenous line, pyrogen- free D-ribose is administered intravenously at a rate of 50-300 mg/kg/hour.

La présente invention concerne ladministration de D-ribose à des patients souffrant dun infarctus aigu du myocarde au cours de soins de première intervention, en vue de prévenir une insuffisance cardiaque. Chez les patients capables dingérer des fluides, on administre oralement deux à cinq grammes de D-ribose. Chez des patients incapables dingérer des fluides, ou chez des patients pourvus dune ligne intraveineuse, on administre de la D-ribose apyrogène par voie intraveineuse à un débit de 50 à 300 mg/kg/heure.

Affiliated with

Also associated with

Rating

Use of ribose in first response to acute myocardial infarction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of ribose in first response to acute myocardial infarction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of ribose in first response to acute myocardial infarction will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2038710